🇺🇸 Agomelatine or PIacebo in United States

Agomelatine or PIacebo (Agomelatine or PIacebo) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Agomelatine or PIacebo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Agomelatine or PIacebo approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Agomelatine or PIacebo in United States?

Second Affiliated Hospital of Soochow University is the originator. The local marketing authorisation holder may differ — check the official source linked above.